Skip to main content

Day: April 21, 2020

Verizon Media launches platform enhancements to maximize streaming reach and revenues

LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — Verizon Media has launched a range of capabilities to enable broadcasters, content owners, and service providers to grow audiences and monetize content in new ways. These include advanced advertising tools that improve transparency in the bidding process and track ad performance. Additional features that maximize audience reach and enhance live event streaming have also been announced.Advanced AdvertisingVerizon Media Smartplay Prebid is a server-side integration that exposes inventory and conducts auctions faster with more demand partners using the prebid open-source framework. This low-risk solution is easy to implement and opens up content owner supply to more demand partners, allows for fair market competition, and provides visibility into content value with price transparency.“Until...

Continue reading

Inphi Reports Preliminary First Quarter 2020 Results

SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NYSE: IPHI), a leader in high-speed data movement interconnects, today announced preliminary financial results for the first quarter of 2020, ending March 31, 2020.Our revenue and operating income are expected to be higher for the first quarter than the midpoint of our February 4th guidance of $132.4M for revenue. Based on the midpoint of the guidance given at that time, the associated GAAP Operating Loss was expected to be ($18.6M) and the Non-GAAP Operating Income was expected to be $25.2M. This result was due primarily to higher revenue in Q1 than anticipated coming from our Cloud customers. Revenue contributed from our January 10th acquisition of eSilicon was also slightly higher than originally anticipated. In addition, as of March 31, 2020, we had $238.2M...

Continue reading

Inphi Corporation Announces Proposed Offering of $330 Million of Convertible Senior Notes

SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NYSE: IPHI) today announced its intention to offer, subject to market conditions and other factors, $330 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, Inphi expects to grant the initial purchasers of the notes an option to purchase up to an additional $50 million aggregate principal amount of notes on the same terms and conditions.Inphi intends to use a portion of the net proceeds from the offering of the notes to pay the cost of certain capped call transactions described below. Inphi also intends to use a...

Continue reading

Builders FirstSource Launches Offering of $250 Million of Senior Secured Notes due 2027

DALLAS, April 21, 2020 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (Nasdaq: BLDR) (the “Company”) today announced that it has launched an offering of $250 million aggregate principal amount of 6.750% Senior Secured Notes due 2027 (the “Notes”). The Notes will form part of the same series as the $400 million aggregate principal amount of 6.750% Senior Secured Notes due 2027 issued on May 30, 2019 and the $75 million aggregate principal amount of 6.750% Senior Secured Notes due 2027 issued on July 25, 2019.The Company intends to use the net proceeds from the offering to repay a portion of the funds drawn under its revolving credit facility and to pay related transaction fees and expenses, with any remaining net proceeds to be used for general corporate purposes.Consummation of the offering of the Notes is...

Continue reading

Aptose to Release First Quarter Ended March 31, 2020 Financial Results and Hold Conference Call on May 5, 2020

SAN DIEGO and TORONTO, April 21, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will release its financial results for the quarter ended March 31, 2020, on Tuesday, May 5, 2020, after the close of the market.The live conference call can also be accessed through a link on the Investor Relations section of Aptose’s website at  https://www.aptose.com/investors/news-events/ir-calendar. An archived version of the webcast along with a transcript will be available on the company’s website for 30 days.The press release, the financial statements and the management’s discussion and analysis for the quarter ended March 31, 2020 will be available on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml.About...

Continue reading

African Gold Group Intersects 22.2m @ 5.25g/t Au From 78.40m and 23.8m @ 1.57g/t Au From 110.50m and Closes the Gap Area With High-grade Intersections

TORONTO, April 21, 2020 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) is pleased to report the final drill results from its extensive diamond drilling program at its Kobada gold project, located in southern Mali. The Company is currently working on an all-encompassing definitive feasibility study (the “DFS”) for the Kobada Gold Project. The Company expects to complete the study in the second quarter of 2020, incorporating the results from Phase 1 and 2 drilling campaigns.Highlights Include (Table 1):14.72g/t Au over 3.15m including 39.70g/t Au over 1.16m from 63.85m to 67m [Drill hole KB19_P2_40]1.18g/t Au over 3.99m including 1.83g/t Au over 1.9m from 36.91m to 40.90m [Drill hole KB19_P2_40]5.25g/t Au over 22.20m including 2.70g/t Au over 1.1m and 103.59g/t Au over 1.0m from 78.40m to 100.60m...

Continue reading

CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by process” patents for obtaining multiple unique cannabis concentrates using super critical fluid extraction (SCFE). These include cannabinoid concentrates enriched in cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG), a non-psychoactive cannabinoid which has shown promising therapeutic activity in animal studies in areas such as inflammatory bowel disease, cancer and infectious diseases.“Adding CBG to our SCFE patent portfolio aligns with the latest research and early clinical evidence supporting its therapeutic benefit,” said Rob Davidson,...

Continue reading

Primoris Services Corporation Announces Change of Location of Annual Meeting of Stockholders

DALLAS, April 21, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced that due to the public health impact of the novel coronavirus (“COVID-19”) outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being of our stockholders, employees and communities, the location of the Annual Meeting of Stockholders of Primoris has been changed. The Annual Meeting will now be held over the internet in a virtual meeting format only, via live webcast.  You will be able to attend the Annual Meeting only via the webcast.There is no change to the proposals to be presented to our stockholders for consideration at the Annual Meeting.  The proxy card included with the proxy materials previously distributed...

Continue reading

Draganfly’s ‘Pandemic Drone’ technology Conducts Initial Flights Near New York City to Detect COVID-19 Symptoms and Identify Social Distancing

Connecticut hotspot becomes first U.S. municipality to test drone technology to assist first responders in reducing coronavirus spread and mitigate future health emergenciesLos Angeles, CA and Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and unmanned vehicle sector, today announced the first ever series of U.S. ‘pandemic drone’ test flights in Westport, Connecticut, considered a COVID-19 ‘hotspot’, to identify social distancing and detect symptoms presented by the virus, in an effort to keep the community safe.Fairfield County, Connecticut is considered the epicenter in the State for the spread of...

Continue reading

Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma

– Overall response rate of 22% –– Disease control rate of 71% –– Median overall survival of 21 months –– Key topline data from ILLUMINATE-301 expected in Q1 2021 –EXTON, Pa., April 21, 2020 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) (the Company) today is announcing final topline data from the ILLUMINATE-204 trial investigating intratumoral tilsotolimod, Idera’s investigational Toll-like receptor 9 (TLR9) agonist.ILLUMINATE-204 is a multi-center, two-arm phase 1/2 trial in patients with anti-PD-1 refractory advanced melanoma. The phase 1 portion of the trial tested the safety and efficacy of increasing doses of tilsotolimod in combination with either Yervoy®* (ipilimumab) or Keytruda®± (pembrolizumab). The phase 2 expansion of the trial enrolled additional patients at the recommended phase 2 dose (RP2D) of 8 mg...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.